INNATE PHARMA
INNATE PHARMA is a Public Limited Company registered in France under 42436533600041, and its current status with INPI (Institut National de la Propriété Industrielle) is active. The company was incorporated on 23 September 1999 and lists its registered address as MARSEILLE, France. 5 shareholders are on record for INNATE PHARMA, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from INPI (Institut National de la Propriété Industrielle) and was last updated on 9 September 2026.
Registration details
Officers
44
Directors and officers of INNATE PHARMA
The Member Of The Supervisory Board of INNATE PHARMA currently on record is Jean-Yves Blay; nine of the 44 officer records shown for INNATE PHARMA are current appointments, filed with INPI (Institut National de la Propriété Industrielle). The remaining 34 records shown (Herve Brailly Ph.d., Irina Staatz Granzer and 31 others) are former appointments that have since been resigned. Management authority at INNATE PHARMA sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 48 officers in total, including past appointments, though only the 44 most relevant records are shown here.
Frequently asked questions
Who owns INNATE PHARMA?
Five shareholders are currently on record for INNATE PHARMA, held on the statuts (articles of association) and filed corporate acts, filed under the Code de commerce. The largest of these is Morgan Stanley, holding 19.6% — the largest recorded stake — followed by Citadel Advisors Llc at 7.3%; the remaining 3 shareholders shown hold smaller stakes. 4 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is INNATE PHARMA's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for INNATE PHARMA is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does INNATE PHARMA have on record?
5 shareholders are shown on record for INNATE PHARMA. The register reports 13 in total; only the top 5 by holding are shown here.
What is INNATE PHARMA's company registration number?
INNATE PHARMA's registration number is 42436533600041, filed with INPI (Institut National de la Propriété Industrielle) in France. Its current status on the register is active.
Is INNATE PHARMA still an active company?
INNATE PHARMA's status on INPI (Institut National de la Propriété Industrielle) is listed as active.
When was INNATE PHARMA incorporated?
INNATE PHARMA was incorporated on 23 September 1999, according to INPI (Institut National de la Propriété Industrielle).
What is INNATE PHARMA's registered address?
The registered address on file for INNATE PHARMA is MARSEILLE, France.
What legal structure is INNATE PHARMA registered as?
INNATE PHARMA is registered as a Public Limited Company in France.
Who are the officers/directors of INNATE PHARMA?
The Member Of The Supervisory Board of INNATE PHARMA currently on record is Jean-Yves Blay; nine of the 44 officer records shown for INNATE PHARMA are current appointments, filed with INPI (Institut National de la Propriété Industrielle). The remaining 34 records shown (Herve Brailly Ph.d., Irina Staatz Granzer and 31 others) are former appointments that have since been resigned. Management authority at INNATE PHARMA sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to INNATE PHARMA's ownership over time?
This profile reflects a point-in-time snapshot from INPI (Institut National de la Propriété Industrielle). Zavia's monitoring API can track changes to INNATE PHARMA's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access INNATE PHARMA's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including France, so records like INNATE PHARMA's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from INPI (Institut National de la Propriété Industrielle) and was last synced on 9 September 2026.